Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Jansen WJ, Handels RL, Visser PJ, Aalten P, Bouwman F, Claassen J, van Domburg P, Hoff E, Hoogmoed J, Leentjens AF, Rikkert MO, Oleksik AM, Smid M, Scheltens P, Wolfs C, Verhey F, Ramakers IH. The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients. J Alzheimers Dis. 2017;55(2):679-689. doi: 10.3233/JAD-160126. PubMed PMID: 27716658.
Janssen EP, de Vugt M, Köhler S, Wolfs C, Kerpershoek L, Handels RL, Orrell M, Woods B, Jelley H, Stephan A, Bieber A, Meyer G, Engedal K, Selbaek G, Wimo A, Irving K, Hopper L, Gonçalves-Pereira M, Portolani E, Zanetti O, Verhey FR. Caregiver profiles in dementia related to quality of life, depression and perseverance time in the European Actifcare study: the importance of social health. Aging Ment Health. 2017 Jan;21(1):49-57. doi: 10.1080/13607863.2016.1255716. Epub 2016 Nov 21. PubMed PMID: 27869480.
Kerpershoek L, de Vugt M, Wolfs C, Jelley H, Orrell M, Woods B, Stephan A, Bieber A, Meyer G, Engedal K, Selbaek G, Handels R, Wimo A, Hopper L, Irving K, Marques M, Gonçalves-Pereira M, Portolani E, Zanetti O, Verhey F. Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study. BMC Health Serv Res. 2016 Aug 23;16(1):423. doi: 10.1186/s12913-016-1672-3. PubMed PMID: 27550084; PubMed Central PMCID: PMC4994155.
Janssen N, Handels RL, Koehler S, Ramakers IH, Hamel RE, Olde Rikkert MG, Scheltens P, Bouwman FH, van der Flier WM, Wolfs CA, de Vugt ME, Evers SM, Verhey FR. Combinations of Service Use Types of People With Early Cognitive Disorders. J Am Med Dir Assoc. 2016 Jul 1;17(7):620-5. doi: 10.1016/j.jamda.2016.02.034. Epub 2016 Apr 9. PubMed PMID: 27073042.
Handels RL, Joore MA, Vos SJ, Aalten P, Ramakers IH, Rikkert MO, Scheltens P, Jansen WJ, Visser PJ, van Berckel BM, van Domburg P, Smid M, Hoff E, Hoogmoed J, Bouwman F, Claassen J, Leentjens AF, Wolfs CA, Severens JL, Verhey FR. Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort. J Alzheimers Dis. 2016 Mar 31;52(3):875-85. doi: 10.3233/JAD-151120. PubMed PMID: 27031483.
Handels RL, Joore MA, Tran-Duy A, Wimo A, Wolfs CA, Verhey FR, Severens JL. Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment. Alzheimers Dement. 2015 Aug;11(8):896-905. doi: 10.1016/j.jalz.2015.02.009. Epub 2015 Jun 9. PubMed PMID: 26071009.
Handels RL, Wolfs CA, Aalten P, Bossuyt PM, Joore MA, Leentjens AF, Severens JL, Verhey FR. Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes. BMC Neurol. 2014 Oct 4;14:190. doi: 10.1186/s12883-014-0190-3. PubMed PMID: 25280531; PubMed Central PMCID: PMC4195860.
Handels RL, Wolfs CA, Aalten P, Joore MA, Verhey FR, Severens JL. Diagnosing Alzheimer's disease: a systematic review of economic evaluations. Alzheimers Dement. 2014 Mar;10(2):225-37. doi: 10.1016/j.jalz.2013.02.005. Epub 2013 May 30. Review. PubMed PMID: 23727080.
Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. J Intern Med. 2014 Mar;275(3):304-16. doi: 10.1111/joim.12167. PubMed PMID: 24605810.
Ossenkoppele R, Prins ND, Pijnenburg YA, Lemstra AW, van der Flier WM, Adriaanse SF, Windhorst AD, Handels RL, Wolfs CA, Aalten P, Verhey FR, Verbeek MM, van Buchem MA, Hoekstra OS, Lammertsma AA, Scheltens P, van Berckel BN. Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimers Dement. 2013 Jul;9(4):414-21. doi: 10.1016/j.jalz.2012.07.003. Epub 2012 Nov 16. PubMed PMID: 23164552.
Handels RL, Xu W, Rizzuto D, Caracciolo B, Wang R, Winblad B, Verhey FR, Severens JL, Fratiglioni L, Joore MA, Wimo A. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease. J Alzheimers Dis. 2013;37(2):357-65. doi: 10.3233/JAD-130296. PubMed PMID: 23948894.
Handels RL, Wolfs CA, Aalten P, Verhey FR, Severens JL. Determinants of care costs of patients with dementia or cognitive impairment. Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):30-6. doi: 10.1097/WAD.0b013e318242da1d. PubMed PMID: 22214890.
Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'Italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging. 2012 Oct;33(10):2272-81. doi: 10.1016/j.neurobiolaging.2011.12.017. Epub 2012 Jan 20. PubMed PMID: 22264648.
Handels RL, Aalten P, Wolfs CA, OldeRikkert M, Scheltens P, Visser PJ, Joore MA, Severens JL, Verhey FR. Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study. BMC Neurol. 2012 Aug 10;12:72. doi: 10.1186/1471-2377-12-72. PubMed PMID: 22883691; PubMed Central PMCID: PMC3460756.
van Rossum IA, Vos S, Handels R, Visser PJ. Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design. J Alzheimers Dis. 2010;20(3):881-91. doi: 10.3233/JAD-2010-091606. Review. PubMed PMID: 20413876.
What would you like to do?
  • Page of 1